Bellerophon Therapeutics Investors

32 investors on Angel Roster list Bellerophon Therapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States, Switzerland and Japan.

Investors are matched on the company name in their portfolio, so companies that share the name Bellerophon Therapeutics can appear together.

Investors listed
32
With verified email
56%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 32 Bellerophon Therapeutics investors

The most complete profiles first. Showing 32 of 32.

  • Andy SchwabVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more

    Verified email available

  • Brian DanielsVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Deborah PalestrantVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jason RuthVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Lou TartagliaVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Verified email available

  • Rebecca ChenVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Adam WeinsteinVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Contact details available

  • Andrew B.Verified

    Private Equity Firm · Japan

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Claudia ZimmermannVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • Daniel RileyVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • David CoquilletteVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Elliot EhrichVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Ignacio SarriaVerified

    Private Equity Firm · United Kingdom

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • John KlineVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Jonathan WeissmanVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Laura HolsonVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Matt HoltVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Paul StoneVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Pete MasucciVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Robert HamweeVerified

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Verified email available

  • Jamil M. Beg

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • John Diekman

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Mason Freeman

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsGeneticsLife Science

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Mira Chaurushiya

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsAlternative MedicineAndroid

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Scott Rocklage

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • A. Joe Delgado

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Contact details available

  • Jack Qian

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Contact details available

  • Joseph Victor

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Peter Kim

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Steve Klinsky

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Contact details available

  • Teddy Kaplan

    Private Equity Firm · United States

    AdvertisingHealth CareHospitalsWomen Founded

    Portfolio: Advance Health, Stroz Friedberg, Ikaria, Apptis, Inc and 14 more

    Contact details available

Frequently asked questions

How many Bellerophon Therapeutics investors are on Angel Roster?

Angel Roster lists 32 Bellerophon Therapeutics investors. 18 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (23), Venture Capital Firms (18) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Bellerophon Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (11).

Where are Bellerophon Therapeutics investors based?

Most are based in the United States (28), Switzerland (2) and Japan (1).

Which companies have Bellerophon Therapeutics investors backed?

The most-backed portfolio companies among them are Bird Rock Bio (18), scPharmaceuticals (16), Epirus Biopharmaceuticals (16), Cidara Therapeutics (16) and Portal Instruments (16).

How do I contact Bellerophon Therapeutics investors?

Create a free Angel Roster account to search and filter all 32, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.